Literature DB >> 25456595

New method for the speciation of ruthenium-based chemotherapeutics in human serum by conjoint liquid chromatography on affinity and anion-exchange monolithic disks.

Anže Martinčič1, Radmila Milačič1, Janja Vidmar1, Iztok Turel2, Bernhard K Keppler3, Janez Sčančar4.   

Abstract

An important step in pharmacological characterisation of a candidate drug is the study of the drugs interactions with serum proteins. In the present work, conjoint liquid chromatography (CLC) was used for separation of ruthenium (Ru)-based drug candidates in human serum. CIM Protein G and CIM DEAE disks were assembled together in a single housing forming a CLC monolithic column. By applying isocratic elution with Tris-HCl-NaHCO3 buffer (pH 7.4) in the first min, followed by gradient elution with 1 mol L(-1) NH4Cl (pH 7.4) in the next 9 min, immunoglobulins (IgG) were retained by the Protein G disk enabling subsequent separation of unbound Ru species from Ru species bound to human serum transferrin (Tf) and albumin (HSA) on the CIM DEAE disk. Finally, elution with acetic acid (AcOH) in the next 3 min allowed separation of Ru species associated with IgG. Protein elution was followed on-line with UV detection at 278nm, while the separated Ru species were quantified by post-column isotope dilution inductively coupled plasma mass spectrometry (ID-ICP-MS). The instrumental set-up enabled fast two-dimensional separation by affinity and ion-exchange modes to be carried out in a single chromatographic run. Two Ru-based chemotherapeutics: a newly synthesised compound chlorido(η6-p-cymene)(nalidixicato-κ2O,O)Ru(II) (1) and (H2im)[trans-Ru(III)Cl4(Him)2] (2; KP418), which is currently undergoing preclinical studies, were investigated. The CLC procedure applied is sensitive with low limit of detection (LOD) (0.027 μg Ru mL(-1) for (1)) and good method repeatability (RSD±3.5%). The experimental data revealed that it enables investigation of the kinetics of interaction of positively charged and neutral complexes of metallodrugs with serum proteins as well as the distribution of metallodrug species in human serum. However, negatively charged metallic complexes co-eluted with Tf and HSA and thus hindered their speciation analysis. An example of successful application of the kinetic studies on the CLC column is (1), a neutral Ru complex that hydrolyses to a positively charged species. For comparison, speciation data obtained for serum samples spiked with cisplatin are also shown.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Affinity monolithic disk; Anion-exchange monolithic disk; Conjoint liquid chromatography; Human serum; Isotope dilution inductively coupled plasma mass spectrometry; Ru-based chemotherapeutics

Mesh:

Substances:

Year:  2014        PMID: 25456595     DOI: 10.1016/j.chroma.2014.10.054

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  4 in total

Review 1.  Affinity monolith chromatography: A review of general principles and recent developments.

Authors:  Saumen Poddar; Sadia Sharmeen; David S Hage
Journal:  Electrophoresis       Date:  2021-08-12       Impact factor: 3.595

2.  A Nanostructured Lipid System to Improve the Oral Bioavailability of Ruthenium(II) Complexes for the Treatment of Infections Caused by Mycobacterium tuberculosis.

Authors:  Patricia B da Silva; Eduardo Sinésio de Freitas; Mariana Cristina Solcia; Paula Carolina de Souza; Monize Martins da Silva; Alzir Azevedo Batista; Carlos E Eismann; Ana Marta C M Rolisola; Amauri A Menegário; Rosilene Fressatti Cardoso; Marlus Chorilli; Fernando R Pavan
Journal:  Front Microbiol       Date:  2018-12-06       Impact factor: 5.640

3.  CORM-3 induces DNA damage through Ru(II) binding to DNA.

Authors:  Rhiannon F Lyon; Hannah M Southam; Clare R Trevitt; Chunyan Liao; Sherif F El-Khamisy; Robert K Poole; Mike P Williamson
Journal:  Biochem J       Date:  2022-07-15       Impact factor: 3.766

4.  Binding Kinetics of Ruthenium Pyrithione Chemotherapeutic Candidates to Human Serum Proteins Studied by HPLC-ICP-MS.

Authors:  Katarina Marković; Radmila Milačič; Stefan Marković; Jerneja Kladnik; Iztok Turel; Janez Ščančar
Journal:  Molecules       Date:  2020-03-26       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.